Overall, on the basis of the available data for validated equations for eGFRcr-cys (involving 2508 patients in whom CKD-EPIcr-cys was assessed in eight studies; Figure 2), the ASON Position Statement Committee advocated for the use of validated equation incorporating both serum creatinine and cystatin C. Here, CST3 is linked to chronic kidney disease.